-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Oyster Point Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2018 to Q3 2022.
- Oyster Point Pharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$33.9M, a 102% decline year-over-year.
- Oyster Point Pharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$158M, a 98.2% decline year-over-year.
- Oyster Point Pharma, Inc. annual Operating Income (Loss) for 2021 was -$96.7M, a 36.2% decline from 2020.
- Oyster Point Pharma, Inc. annual Operating Income (Loss) for 2020 was -$71M, a 50.1% decline from 2019.
- Oyster Point Pharma, Inc. annual Operating Income (Loss) for 2019 was -$47.3M, a 183% decline from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)